Javier Castillo, MD, serves The Mount Sinai Hospital as Director of the Hispanic Heart Center. In addition, Dr. Castillo is the Executive Director of the Mitral Foundation and the International Director of the Structural Heart Disease Program at Universidad Complutense in Madrid, Spain.
Dr. Castillo received his medical education at Universitat Rovira I Virgili and pursued further postgraduate education at Mayo Clinic. He then completed his internship and residency in cardiothoracic surgery at The Mount Sinai Hospital and the Icahn School of Medicine at Mount Sinai. In addition, Dr. Castillo completed a research fellowship under Professor David H. Adams in the Department of Cardiovascular surgery at the Icahn School of Medicine at Mount Sinai.
As a surgeon scientist, Dr. Castillo has consistently delivered excellent leading work in different areas including experimental animal research and outcome analysis in cardiothoracic surgery. His research has been presented in the most prestigious scientific conferences and has contributed to advancing the understanding and management of heart valve disease. Dr. Castillo is an author on over 100 peer-reviewed publications and serves on the Editorial Boards of several medical journals and textbooks. He has authored over 25 book chapters on the surgical management of mitral valve disease for the top textbooks in the cardiovascular field including Hurst’s the Heart, Braunwald’s Heart Disease, Sabiston and Spencer Surgery of the Chest or Cardiac Surgery in the Adult. Dr. Castillo is a much sought-after international speaker, particularly in Latin America, and currently plays a leading role in the organization of Conclave Mitral, one of the world’s largest surgical workshop on valve reconstruction in Spanish. He also serves in an advisory capacity to several industry leaders in cardiovascular surgery and holds several patents.
Dr. Castillo’s clinical interests include all aspects of complex valve disease, with a special emphasis on mitral valve reconstruction, aortic root surgery, multivalve surgery and novel percutaneous valve replacement.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Castillo did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
- Chapter 16: Mitral Valve Repair, Javier G. Castillo, MD and David H. Adams, MD
- Javier G. Castillo, MD, George Silvay, MD and Percy Boateng, MD
- Javier Castillo, MD, Fred Milla, MD, Anelechi C. Anyanwu, MD, and David H. Adams, MD
All anterior and bileaflet mitral valve prolapses are repairable in the modern era of reconstructive surgery.Javier G. Castillo, MD, Anelechi C. Anyanwu, MD, Ahmed El-Eshmawi, MD and David H. Adams, MD